These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10202180)

  • 1. Are aberrant transcripts of FHIT, TSG101, and PTEN/MMAC1 oncogenesis related?
    Wang NM; Chang JG
    Int J Mol Med; 1999 May; 3(5):491-5. PubMed ID: 10202180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant transcripts of FHIT, TSG101 and PTEN/MMAC1 genes in normal peripheral mononuclear cells.
    Wang NM; Chang JG; Liu TC; Lin SF; Peng CT; Tsai FJ; Tsai CH
    Int J Oncol; 2000 Jan; 16(1):75-80. PubMed ID: 10601551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
    Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma.
    Yeh KT; Chang JG; Chen YJ; Chen ST; Yu SY; Shih MC; Perng LI; Wang JC; Tsai M; Chang CP
    Cancer Invest; 2000; 18(2):123-9. PubMed ID: 10705874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer.
    Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH
    Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
    Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
    Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract.
    Chang JG; Chen YJ; Perng LI; Wang NM; Kao MC; Yang TY; Chang CP; Tsai CH
    Eur J Cancer; 1999 Apr; 35(4):647-51. PubMed ID: 10492641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TSG101 in uterine cervix cancer.
    O'Boyle JD; Proctor ML; Fong KM; Lin WM; Miller DS; Muller CY
    Gynecol Oncol; 1999 Dec; 75(3):401-5. PubMed ID: 10600297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
    Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
    Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor genes in lung cancer.
    Virmani AK; Gazdar AF
    Methods Mol Biol; 2003; 222():97-115. PubMed ID: 12710682
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells.
    Matthews CP; Shera K; Kiviat N; McDougall JK
    Oncogene; 2001 Aug; 20(34):4665-75. PubMed ID: 11498789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant splicing of the TSG101 tumor suppressor gene in human breast and ovarian cancers.
    Carney ME; Maxwell GL; Lancaster JM; Gumbs C; Marks J; Berchuck A; Futreal PA
    J Soc Gynecol Investig; 1998; 5(5):281-5. PubMed ID: 9773405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.
    Huiping C; Kristjansdottir S; Bergthorsson JT; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
    Eur J Cancer; 2002 Mar; 38(5):728-35. PubMed ID: 11916557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identical variant TSG101 transcripts in soft tissue sarcomas and various non-neoplastic tissues.
    Willeke F; Ridder R; Bork P; Klaes R; Mechtersheimer G; Schwarzbach M; Zimmer D; Kloor M; Lehnert T; Herfarth C; von Knebel Doeberitz M
    Mol Carcinog; 1998 Dec; 23(4):195-200. PubMed ID: 9869447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 induction prevents accumulation of aberrant transcripts in cancer cells.
    Moyret-Lalle C; Duriez C; Van Kerckhove J; Gilbert C; Wang Q; Puisieux A
    Cancer Res; 2001 Jan; 61(2):486-8. PubMed ID: 11212237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.
    Fujii GH; Morimoto AM; Berson AE; Bolen JB
    Oncogene; 1999 Mar; 18(9):1765-9. PubMed ID: 10208437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.
    Lee SH; Kim WH; Kim HK; Woo KM; Nam HS; Kim HS; Kim JG; Cho MH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):850-5. PubMed ID: 11396980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
    Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
    Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent abnormalities of TSG101 transcripts in human prostate cancer.
    Sun Z; Pan J; Bubley G; Balk SP
    Oncogene; 1997 Dec; 15(25):3121-5. PubMed ID: 9444960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.